Participation
wart, acute febrile diseases
WART, ANAPHYLACTIC REACTION, AUTOIMMUNE DISORDERS, SEXUALLY TRANSMITTED DISEASES, ANOGENITAL WARTS, WARTS
During the study period, 83 patients with AGWs were assessed for their eligibility to be included in the study based on specific inclusion and exclusion criteria. Assessment included detailed history taking (personal history, history of present illness, including previous treatment for warts, history of systemic, other dermatological, or sexually transmitted diseases, and history of warts among sexual partners and other family members), and a thorough dermatological examination (to confirm the clinical diagnosis of AGWs, determine the distribution, number, and size of warts, and exclude other dermatological diseases).Patients aged 12 years old or more from either sex with clinically diagnosed multiple (≥ 5 warts) genital, perianal, or anogenital warts were included. Patients younger than 12 years old, pregnant or lactating females, those with acute febrile diseases, autoimmune disorders, or immunosuppressive conditions, those with a history of serious systemic or anaphylactic reactions to Candida antigen or HPV vaccines, and those who had received any type of wart therapy in the previous month were all excluded.Based on these criteria, a total of 80 patients with multiple AGWs were enrolled in the interventional phase of the study.